Stockscreener 앱 받기
46.00
0.31%
0.1999
전일 마감가:
$45.80
열려 있는:
$45.82
하루 거래량:
2,999
Relative Volume:
0.28
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.99%
1개월 성능:
+5.11%
6개월 성능:
+49.16%
1년 성능:
+8.76%
1일 변동 폭
$45.62
$46.00
1주일 범위
$42.02
$46.00
52주 변동 폭
$27.20
$46.00
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
GNOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
46.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.46 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
679.71 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
683.12 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
257.69 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.77 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf 주식(GNOM)의 최신 뉴스
Understanding Momentum Shifts in (GNOM) - news.stocktradersdaily.com
Atria Investments Inc Boosts Stake in Global X Genomics & Biotechnology ETF $GNOM - Defense World
Global X Genomics & Biotechnology ETF (GNOM) Stock Price Quote Today & Current Price Chart - Capital.com
Avoiding Lag: Real-Time Signals in (GNOM) Movement - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
Biotechnology: Pioneering The Future Of Medicine - Seeking Alpha
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Biotechnology: Pioneering the Future of Medicine - Global X ETFs
Astoria US Quality Growth Kings ETF (NASDAQ:GQQQ) Sees Large Increase in Short Interest - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Update - Defense World
First Trust Health Care AlphaDEX Fund (NYSEARCA:FXH) Short Interest Up 187.5% in September - Defense World
Discipline and Rules-Based Execution in GNOM Response - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure - MSN
6 Best AI Drug Discovery Stocks in 2025 - StocksToTrade
CRSP Stock: How to Invest in CRISPR Therapeutics - The Motley Fool
HighTower Advisors LLC Acquires 2,184 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Re-rating Opportunities in Health Care Amid Sector Rotation and Regulatory Risk - AInvest
Investment Guide to Genetics Stocks and ETFs - NAI500
Investing in the DNA of Tomorrow: Explore Gene Stocks and Genomics ETFs - Investing News Network
How to Invest in Gene Stocks and ETFs - Nasdaq
The Next Big Theme: August 2025 - Seeking Alpha
Global X Announces Five ETF Reverse Stock Splits - Eastern Progress
7 Best Biotech ETFs to Buy Now - US News Money
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Global X Fds Genomics & Biotechnology Etf To Carry Out 1-for-4 Reverse Stock Split On September 2nd, 2025 - 富途牛牛
The Next Big Theme: July 2025 - Seeking Alpha
Stratos Wealth Partners LTD. Buys 2,865 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - 富途牛牛
Middlefield Healthcare Dividend ETF: A Strategic Play on Dividend Income and Sector Resilience - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Price Passes Above 200-Day Moving Average of $13.45 - 富途牛牛
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Position Increased by Portland Global Advisors LLC - 富途牛牛
(GNOM) Investment Analysis and Advice - news.stocktradersdaily.com
Jack Reed Net Worth - Quiver Quantitative
The long game: ASX ETFs to target amidst an ageing population - The Motley Fool Australia
Global X Genomics & Biotechnology ETF declares semi-annual distribution of $0.0083 - MSN
3 ASX ETFs that could be good value right now - The Motley Fool Australia
Oppenheimer Asset Management Inc. Has $659,000 Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
The Next Big Theme: June 2025 - Global X ETFs
Learn to Evaluate (GNOM) using the Charts - news.stocktradersdaily.com
Gene Therapy Stocks Fall Amid More Turmoil at FDA - Barron's
Should we bet on a biotech revival? - marketscreener.com
Douglas Dynamics, Inc. (NYSE:PLOW) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Rush Street Interactive (NYSE:RSI) Raised to Strong-Buy at Wall Street Zen - Defense World
15,215 Shares in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Acquires Shares of 10,644 Mastech Digital, Inc. (NYSE:MHH) - Defense World
Citadel Advisors LLC Acquires New Position in Global X Aging Population ETF (NASDAQ:AGNG) - Defense World
8,047 Shares in Innovator U.S. Equity 5 to 15 Buffer ETF – Quarterly (BATS:EALT) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Grows Stake in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Two Sigma Investments LP Raises Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Bank of America Corp DE Cuts Stock Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Global X Genomics Biotechnology Etf (GNOM) 재무 분석
Global X Genomics Biotechnology Etf (GNOM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.66%
자본화:
|
볼륨(24시간):